Physician profile
Eileen Trokhan
NPI 1447214804
$1,897.71
in general payments reported to CMS, 2019-2025
20 companies · $609 in 2025
The $609 reported for 2025 was more than what 82% of providers received nationally.
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $472 · 2020: $72.79 · 2021: $27.97 · 2022: $196 · 2023: $179 · 2024: $342 · 2025: $609.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,129.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,129.33 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ucb, INC. | $424.77 | 2022-2025 | Bimzelx |
| Galderma Laboratories, L.P. | $320.43 | 2019-2025 | Dysport, Nemluvio, Aklief |
| Abbvie INC. | $308.49 | 2022-2025 | Rinvoq |
| Allergan, INC. | $193.48 | 2019 | |
| Arcutis Biotherapeutics, INC. | $95.76 | 2023-2024 | Zoryve |
| Organon LLC | $85.64 | 2025 | Vtama |
| Pfizer INC. | $73.68 | 2020-2025 | |
| Novartis Pharmaceuticals Corporation | $65.09 | 2019 | |
| Lilly USA, LLC | $58.24 | 2019-2022 | |
| Mayne Pharma Commercial LLC | $52.13 | 2019-2023 | |
| Janssen Biotech, INC. | $39.08 | 2019-2025 | Tremfya, Stelara, Simponi Aria |
| Incyte Corporation | $33.63 | 2023-2025 | Opzelura |
| Amgen INC. | $31.86 | 2022-2023 | Otezla |
| Stryker Corporation | $25.00 | 2025 | Pangea |
| Sun Pharmaceutical Industries INC. | $18.83 | 2025 |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Mission Pharmacal Company | $16.31 | 2020 | |
| Celgene Corporation | $14.95 | 2019 | |
| Biofrontera INC. | $14.03 | 2021 | |
| Ortho Dermatologics, A Division of Bausch Health US, LLC | $13.32 | 2020 | |
| Leo Pharma INC. | $12.99 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Eileen Trokhan listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.